• SENSEX 73,380.91
    -217.76 (--0.30%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,161.90 1,152.30(%)
  • Piramal Pharma
    234.35 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • Cholaman.Inv.&Fn
    1,533.35 1,952.00(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • One 97
    1,600.10 947.10(%)
  • Ola Electric
    37.44 51.84(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Sahajanand Medi
    558.80 493.20(%)
  • Patanjali Foods
    351.70 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • OneSource Speci.
    1,561.70 1,075.00(%)
  • Infosys
    1,103.50 980.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Acutaas Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 73056.0
  • ISIN : INE00FF01025
3,793.30 445 (13.27%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    3,360.50

  • Today’s High

    3,900.00

  • Open

    3,365.00

  • Perv Close

    3,348.80

  • 52W Low

    1,570.00

  • 52W High

    3,900.00

Key Indicators

  • P/E(TTM)

    67.49

  • Mar.Cap (₹Cr.)

    31,056.17

  • Div & Yield %

    0.07

  • Book Value(₹)

    227.78

  • Debt-Equity Ratio

    13.27

  • AGM Date

    27-Oct-2026

  • EPS

    56.22

  • P/E Ratio

    67.49

Financials Ratios

  • Debt-Equity Ratio

    0.17

  • Mar.Cap (₹Cr.)

    31,056.17

  • RONW (%)

    10.67

  • ROCE (%)

    16.07

Score Board

  • Equity (₹ in Cr.)

    40.94

  • BV (₹)

    227.80

  • Sales( ₹ in Cr.)

    1,323.79

  • NP (in Cr.)

    363.91

  • NP Var(%)

    132.0

  • Div%

    50.0

  • CPS (₹)

    48.50

  • EPS (₹)

    44.40

  • Traded Value (₹ in Lakhs)

    31,066.41

  • 52 Week High

    3,900.00

  • 52 Week Low

    1,570.00

  • Price BSE

    3795.0

  • Price NSE

    3,793.00

  • Market Capital( in Cr.)

    31,066.41

  • P/C Ratio

    78.30

  • P/E Ratio

    85.40

  • Price Vs.BV

    44.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,323.79 989.83 687.58 616.73 520.14 340.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,323.79 989.83 687.58 616.73 520.14 340.61
Other Income 45.88 18.34 13.79 4.32 2.76 1.33
Stock Adjustments 30.69 18.65 26.94 14.96 9.50 -4.81
Total Income 1,400.36 1,026.82 728.31 636.01 532.40 337.13
EXPENDITURE :            
Raw Materials 592.50 566.84 434.96 345.85 282.33 174.87
Power and Fuel Cost 37.15 29.99 25.69 22.28 21.40 5.26
Employee Cost 111.35 80.95 60.92 48.84 41.37 20.99
Other Manufacturing Expenses 66.04 51.23 47.46 46.71 49.53 40.65
Selling and Administration Expenses 55.65 45.84 32.33 36.56 27.22 11.47
Miscellaneous Expenses 8.78 8.49 37.26 8.78 2.61 2.35
Employee Benefit Expenses 111.35 80.95 60.92 48.84 41.37 20.99
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 871.48 783.34 638.61 509.03 424.45 255.59
Operating Profit 528.89 243.48 89.69 126.98 107.94 81.53
Interest 3.08 5.86 5.89 2.41 6.41 5.62
Gross Profit 525.81 237.62 83.80 124.57 101.53 75.91
Depreciation 33.03 24.05 14.69 12.34 10.08 4.19
Profit Before Tax 492.78 213.57 69.11 112.23 91.45 71.72
Current Tax 115.49 46.97 20.91 26.38 16.72 17.56
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 11.11 7.06 4.51 2.50 2.78 0.16
Reported Net Profit 366.17 159.55 43.68 83.34 71.95 54.00
Extraordinary Items 2.26 2.61 -15.35 -0.55 -0.10 -0.61
Adjusted Net Profit 363.91 156.94 59.03 83.89 72.05 54.61
Adjustment below Net Profit -0.29 -0.11 -0.09 0.17 0.00 -21.03
P & L Balance brought forward 455.40 308.24 275.58 203.00 131.28 97.48
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.28 12.28 10.93 10.93 0.00 0.00
P & L Balance carried down 809.01 455.40 308.24 275.58 203.23 130.45
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 30.00 30.00 30.00 30.00 0.00
Dividend Per Share(Rs) 2.50 1.50 3.00 3.00 3.00 0.00
Earnings Per Share-Unit Curr 44.73 19.49 11.84 22.87 19.75 17.14
Earnings Per Share(Adj)-Unit Curr 44.73 9.75 5.92 11.44 9.88 -
Book Value 203.78 160.21 183.05 161.04 142.16 52.05
Book Value(Adj)-Unit Curr 203.78 80.11 91.53 80.52 71.08 -

Shareholding Pattern

  • Promoter Group

    32.66%

  • Public Share Holding

    67.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 41 0.00 41 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 26,741,416 32.66 26,741,416 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,741,457 32.66 26,741,457 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,473 0.01 8,473 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 18,516,468 22.62 18,516,468 274
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,977,920 3.64 2,977,920 17
Mutual Funds / UTI 11,823,523 14.44 11,823,523 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,081,625 1.32 1,081,625 35
Trusts 8 0.00 8 1
Venture Capital Funds 0 0.00 0 0
Sub total 34,408,017 42.03 34,408,017 360
2] Non Institution
Bodies Corporate 1,047,951 1.28 1,047,951 1,038
Clearing Members 156,731 0.19 156,731 30
Directors of their Relatives 623,200 0.76 623,200 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,006,357 1.23 1,006,357 4,281
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 473,101 0.58 473,101 3,044
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,205,188 7.58 6,205,188 17
Individuals holding nominal share capital up to Rs. 1 lakh 11,110,475 13.57 11,110,475 138,152
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 71,920 0.09 71,920 13
Others 2,500 0.00 2,500 2
Sub Total 20,721,648 25.31 20,721,648 146,662
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 81,871,122 100.00 81,871,122 147,026

Company Background

Acutaas Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Acutaas Chemicals Ltd
  • BSE Code : 73056.0
  • ISIN : INE00FF01025

  • Incorporation Year

    2007

  • Registered Office

    Plot No 440/4 5&6
    Road No 82/A GIDC Sachin, Surat,
    Gujarat-394230

  • Telephone

    91-261-2397193/91-7227977744

  • FAX

    91-261-2398436

  • Chairman

    Nareshbhai Ramjibhai Patel

  • Managing Director

    Nareshbhai Ramjibhai Patel

  • Company Secretary

  • Auditor

    Maheshwari & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Acutaas Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Acutaas Chemical 3,794.55 1,369.67 1,323.79 67.49 32.74
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77